Healthcare · Healthcare Software
OpenEvidence
Series D
Implied valuation
$00 B
Live tracking
IPO Odds00 %modeled estimate
Probability modeled from funding stage, momentum & liquidity signals.
Valuation Trajectory
1.5K×
since foundingJun 2016Jun 2026
Funding-round staircase from founding · log scale. Modeled round ladder anchored to the current valuation — illustrative, not a published figure.
IPO Model Drivers
Why the odds read this way
Valuation momentum
+105.2% trailingFinancing stage
Series DScale & liquidity pull
Private-market valuationFactor weights are illustrative decompositions of the modeled IPO probability, not guarantees.
Down-Round Risk
Valuation downside pressure
Moderate
Mixed signals — limited valuation history with 56% modeled IPO odds keep down-round risk in the middle band.
Asset brief
OpenEvidence is a Healthcare · Healthcare Software company last marked at $12B. Stage: Series D. No verified market-moving events in the last 30 days.
Capital Timeline
Funding & liquidity milestones
Series D
$12B
Backed by
No disclosed investors yet.
Comparables
Healthcare
Signals
No recent signals for OpenEvidence.